| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 9,600,564 | 7,832,062 | 6,578,928 | | Cost of Revenue | 6,242,460 | 5,057,610 | 4,217,806 | | | Gross Profit | 3,358,104 | 2,774,452 | 2,361,122 | | | Operating Expenses | | Research Development | 192,659 | 169,317 | 149,429 | | Selling General and Administrative | 1,268,240 | 980,799 | 877,314 | | Non Recurring | (81,344) |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,978,549 | 1,624,336 | 1,334,379 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (44,956) | 3,278 | (6,409) | | Earnings Before Interest And Taxes | 1,933,593 | 1,627,614 | 1,333,800 | | Interest Expense | 243,679 | 183,128 | 109,577 | | Income Before Tax | 1,689,914 | 1,444,486 | 1,224,223 | | Income Tax Expense | 288,811 | 332,760 | 316,524 | | Minority Interest | (34,272) | (19,751) | (11,330) | | | | Net Income From Continuing Ops | 1,366,831 | 1,091,975 | 896,369 | | | Non-recurring Events | | Discontinued Operations | (12,928) | (21,369) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,353,903 | 1,070,606 | 896,369 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,353,903 | $1,070,606 | $896,369 |
|
1.48% Nasdaq 
Income Statement
